AlphaYouDI
Schedule 13G filing
Dauntless Investment Group, LLC disclosed a 5.4% stake in Kazia Therapeutics Ltd (KZIA)
Dauntless Investment Group, LLC reported owning 5.4% of Kazia Therapeutics Ltd (KZIA) (842,340 shares) in a Schedule 13G filed Oct 2, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.